Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Iridex Q2 2024 GAAP EPS $(0.16) Misses $(0.11) Estimate, Sales $12.631M Miss $12.800M Estimate

Author: Benzinga Newsdesk | August 08, 2024 05:15pm
Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.11) by 45.45 percent. This is a 5.88 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $12.631 million which missed the analyst consensus estimate of $12.800 million by 1.32 percent. This is a 1.74 percent decrease over sales of $12.855 million the same period last year.

Posted In: IRIX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist